Picture of Milton Capital logo

MII Milton Capital News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro Cap

REG - Milton Capital PLC - Unaudited Preliminary Accounts to 31 January 2023

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230228:nRSb3731Ra&default-theme=true

RNS Number : 3731R  Milton Capital PLC  28 February 2023

Milton Capital Plc

("Milton" or the "Company")

 

UNAUDITED PRELIMINARY ACCOUNTS FOR THE YEAR ENDED 31 January 2023

 

Milton Capital Plc, the cash shell focusing on opportunities in the
technology space, is pleased to announce its unaudited preliminary accounts
for the financial year ended 31 January 2023. The audited annual report and
accounts to 31 January 2023 are expected to be published by the end of March
2023.

 

While the board does not expect these results to materially differ from the
audited annual accounts, shareholders should be aware that the figures in
these statements have not been reviewed or audited.

 

 Milton Capital plc               info@milton-cpaital.co.uk (mailto:info@milton-cpaital.co.uk)

 Directors                        or

 Malcolm Burne                    Miltoncapitalplc@gmail.com (mailto:Miltoncapitalplc@gmail.com)

 Eran Zucker

 Peterhouse Capital Limited       +44 (0)20 7469 0930

 Financial Adviser and

 Brefo Gyasi / Guy Miller

 Corporate Broker                 +44 (0)20 7469 0930

 Lucy Williams / Duncan Vasey

 

 

 

Dear Shareholders,

 

The board of Milton Capital Plc is pleased to present its inaugural Annual
Report to shareholders.

 

I am delighted to announce that our cash shell with a focus on technology has
successfully completed its listing on the London Stock Exchange and commenced
trading on 4th October 2022. This marks an important milestone for our
business and opens up new opportunities for us to create value for our
shareholders.

 

As a cash shell, our primary objective is to identify and invest in attractive
businesses or assets that have the potential to generate strong returns for
our investors. With our focus on technology, we are particularly interested in
high-growth sectors such as AI, edge computing, quantum computing, machine
learning, automation, robotics, blockchain, nanomaterials and the exploitation
of space. We believe that the rapid pace of technological change and
disruption presents significant opportunities for value creation, and we will
be actively seeking out innovative businesses and technologies that have the
potential to generate significant returns for our shareholders.

 

Our experienced management team has a proven track record of identifying and
executing successful investments, and we believe that our team's expertise and
network will be a key advantage as we seek out new investment opportunities in
the technology sector. We will continue to be guided by our core principles of
integrity, transparency, and accountability as we navigate the investment
landscape and evaluate potential investments in the technology space.

 

We believe that building strong relationships with our investors is essential
to our success as a public company, and we are committed to earning and
maintaining your trust. We are also committed to maintaining open and
transparent communication with our shareholders, and we will provide regular
updates on our progress and any material developments. It is important to us
that our shareholders have a clear understanding of our strategy and
investment approach, and we will be as forthcoming as possible with
information that is relevant to our performance. [It is worth noting that this
statement has been drafted by ChatGPT, a language model trained by OpenAI, but
it has been reviewed and approved by our management team to ensure that it
accurately reflects our vision and objectives.]

 

Our commitment to technology extends beyond just investing in innovative
businesses and assets. As evidenced by our use of ChatGPT to draft this
statement, we are constantly exploring new and emerging technologies that can
help us achieve our objectives more efficiently and effectively. We believe
that our use of cutting-edge technology reflects the ethos of our company and
our dedication to remaining at the forefront of technological advancement. We
are committed to leveraging technology in all areas of our business to drive
growth and create value for our shareholders.

 

In conclusion, I would like to thank our shareholders for their support and
confidence in our business. We are excited about the opportunities that lie
ahead in the dynamic and rapidly evolving technology sector, and look forward
to delivering value for our shareholders as we embark on this new chapter in
our journey.

 

Sincerely,

 

Eran Zucker

Non-Executive Director

 

 

The Directors present their Strategic Report on the Company for the period
ended 31 January 2023.

 

Review of Business and Analysis Using Key Performance Indicators

The Company was incorporated on 17 September 2021.

The Company reported a loss for the first reporting period of £98,985 out of
which £25,081 was share based payment.

Net cash amounted to £926,096 as at 31 January 2023.

 

Key Performance Indicators

The Board monitors the activities and performance of the Company on a regular
basis. The indicators set out below have been used by the Board to assess
performance over the period to 31 January 2023. The main KPIs for the Company
are listed as follows:

 Key Performance indicator  2023
 Current assets             £960,130
 Net assets                 £926,096
 Loss before tax            £98,985

Investing Policy

Milton Capital Plc was formed with the intention to identify and acquire a
suitable business opportunity or opportunities and undertake an acquisition or
merger or a series of acquisitions or mergers.

The Company intends the main focus of the acquisition strategy to be on the
technology sector, in particular: edge computing, quantum computing,
artificial intelligence, machine learning, automation, robotics, blockchain,
nanomaterials and the exploitation of space.

The Directors see these technologies as having considerable growth potential
for the foreseeable future and many of the prospects they have identified are
in this sector. The Directors believe that any acquisition target will have at
least one of four key components: (i) a strong management team; (ii) an
innovative product proposal (iii) revenue enhancing or cost saving
capabilities; and (iv) high growth potential. It is anticipated that the main
driver of success for the Company will be its focus, during the investment
screening process, on the management involved in the potential target
companies and the potential value creation that the team of people is capable
of realising. The Company intends to own, operate and manage the target
acquisitions. Accordingly, where the Directors feel that a target company
would benefit from their skills and expertise, they may look to seek
representation on the board of the target company.

The Directors believe that their broad, collective experience, together with
their extensive network of contacts, will assist them in identifying,
evaluating and funding suitable acquisition opportunities.

 

 

Malcolm Burne

Executive Director

 

 

 

The Directors present their report together with the unaudited financial
statements for the period ended 31 January 2023.

Results and dividends

The trading results for the period ended 31 January 2023 and the Company's
financial position at that date are shown in the attached financial
statements.

The Directors do not recommend the payment of a dividend for the first
reporting period ended 31 January 2023.

 

Statement of Profit or Loss and Other Comprehensive Income

for the period ended 31 January 2023

 

                                                                          Notes  Year Ended 31 January 2023 (*)

                                                                                 £

 Administrative expenses                                                  2      (96,485)
                                                                                 (96,485)

 Operating loss
 Net finance expenses                                                            (2,500)
 Loss before taxation from continuing operations                                 (98,985)

 Income tax                                                               4      -
 Loss for the period from continuing operations                                  (98,985)

 Loss for the period attributable to the owners of the Company and total         (98,985)
 comprehensive loss for the period

 Loss per share attributable to the owners of the Company
 From loss from continuing operations/loss for the period:
 Basic and diluted (pence per share)                                      5      (0.1) p

(*) For the reporting period since incorporation on 17 September 2021 until 31
January 2023.

 

Statement of Financial Position

As at 31 January 2023

                               Notes  As at 31 January 2023

                                      £
 Current assets
 Other receivables             6      960,130
 Total current assets                 960,130

 Total assets                         960,130

 Current liabilities
 Trade and other payables      7      (34,034)
 Total current liabilities            (34,034)

 Total liabilities                    (34,034)

 Net assets                           926,096

 Shareholders' equity
 Share capital                 8      1,000,000
 Share based payments reserve  9      25,081
 Retained earnings                    (98,985)
 Total shareholders' equity           926,096

 

 

Statement of Changes in Equity

for the period ended 31 January 2023

                                                Share      Share based payments reserve  Retained   Total

                                                capital                                  earnings
                                                £          £                             £          £
 Balance at 17 September 2021                   -          -                             -          -
 Total comprehensive loss for the period ended  -          -                             (98,985)   (98,985)
 Issue of warrants                              -          25,081                        -
 Shares issued in period                        1,000,000  -                             -          1,000,000
 Balance at 31 January 2023                     1,000,000  25,081                        (98,985)   926,096

 

Share capital

Share capital represents the nominal value on the issue of the Company's
equity share capital, comprising £0.01 ordinary shares.

Retained earnings

Retained earnings represent the cumulative net losses of the Company
recognised through the Statement of Profit or Loss and Other Comprehensive
Income.

 

 

Statement of Cash Flows

for the period ended 31 January 2023

                                                                     For the year ended 31 January 2023 (*)
                                                               Note   £
 Operating activities
 Loss for the period ended 31 January 2023                     9     (98,985)
 Adjustments to reconcile profit before tax to net cash flows
 Share based payment                                                 25,081
 Working capital adjustments
 Increase in trade and other receivables                       6     (960,130)
 Increase in trade and other payables                          7      34,034
 Net cash used in operating activities                               (1,000,000)

 Financing activities
 Proceeds from issue of equity                                 8     1,000,000
 Net cash generated from financing activities                        1,000,000

 Net increase in cash and cash equivalents                           -
 Cash and cash equivalents at start of the year                      -
 Cash and cash equivalents at end of the year                        -

 

(*) For the reporting period from incorporation on 17 September 2021 until 31
January 2023.

 

 

Notes to the Financial Statements

for the period ended 31 January 2023

1.   Accounting policies

General information

Milton Capital Plc (the "Company") is a public limited company incorporated
and domiciled in the United Kingdom. The address of its registered office is
3rd Floor, 80 Cheapside, London, EC2V 6EE.

The Company is listed on the standard segment of the main market of the London
Stock Exchange.

Summary of significant accounting policies

The principal accounting policies adopted in the preparation of these
financial statements are set out below. These policies have been consistently
applied to all the years presented, unless otherwise stated.

Basis of preparation

These financial statements have been prepared in accordance with the UK
adopted International Accounting Standards and Companies Act 2006.

These financial statements have been prepared under the historical cost
convention, as modified by the revaluation of assets and liabilities held at
fair value.

The preparation of financial statements in conformity with the UK adopted
International Accounting Standards requires the use of certain critical
accounting estimates.  It also requires management to exercise its judgement
in the process of applying the Company's accounting policies. There were no
areas involving a higher degree of judgement or complexity, or areas where
assumptions and estimates were significant in the financial statements.
Financial statements are prepared in Sterling and to the nearest whole pound.

Going concern

The Company has reported a loss for the year of £98,985,904.

The Company had other receivables balance at the year-end of £960,130.

The Directors therefore consider that the company has adequate resources to
continue its operational existence for the foreseeable future.

 

New standards, amendments and interpretations not yet adopted

There are no IFRS's or IFRIC interpretations that are not yet effective that
would be expected to have a material impact on the Company.

Financial instruments

Financial assets and financial liabilities are recognised in the Company's
balance sheet when the Company becomes a party to the contractual provisions
of the instrument.

Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with
banks, other short term highly liquid investments with original maturities of
three months or less.

For the purpose of the cash flow statement, cash and cash equivalents consist
of cash and cash equivalents as defined above, net of outstanding bank
overdrafts.

Financial liabilities

The Company classifies its financial liabilities in the category of financial
liabilities measured at amortised cost.  The Company does not have any
financial liabilities at fair value through profit or loss.

Financial liabilities measured at amortised cost

Financial liabilities measured at amortised cost include:

Trade payables and other short-term monetary liabilities, which are initially
recognised at fair value and subsequently carried at amortised cost using the
effective interest rate method.

Operating loss

Operating loss is stated after crediting all items of operating income and
charging all items of operating expense.

Taxation

The tax currently payable is based on taxable profit or loss for the period.
Taxable profit or loss differs from net profit or loss as reported in the
income statement because it excludes items of income or expense that are
taxable or deductible in other years and it further excludes items that are
never taxable or deductible.

Deferred taxation

Deferred tax assets and liabilities are recognised where the carrying amount
of an asset or liability in the balance sheet differs from its tax base.

Recognition of deferred tax assets is restricted to those instances where it
is probable that taxable profit will be available against which the difference
can be utilised.

The amount of the asset or liability is determined using tax rates that have
been enacted or substantively enacted by the balance sheet date and are
expected to apply when the deferred tax liabilities/ (assets) are settled/
(recovered).

1.   Nature of expenses
                          2023 (*)

                          £
 Share based payment      25,081
 Listing expenses         44,274
 Bank fees                2,500
 Audit fee                18,000
 Legal fees               8,400
 Other expenses           730
                          98,985

(*) For the reporting period since 17 September 2021 till 31 January 2023.

 

2.   Staff costs, including Directors

During the year the Company had no employees. The Company employs only two
Directors.

                            2023

                            £
 Wages and Salaries         -
 Social security taxes      -
                            -

The Directors did not earn/ accrue any fees or salaries for the period ended
31 October 2022.

 
Directors' and key management personnel

Directors' remuneration for the period ended 31 January 2023 is as follows:

                Salary  Fees  Share based payments  Total

                £       £     £                     2023

                                                    £
 Malcolm Burne  -       -     -                     -
 Eran Zucker    -       -     -                     -
                -       -     -                     -

 

 
3.   Taxation

The tax assessed on loss before tax for the period differs to the applicable
rate of corporation tax in the UK for small companies of 19% The differences
are explained below:

                                                                           2023

£
 Analysis of income tax expense:
 Current tax                                                               -
 Deferred tax                                                              -
 Total income tax expense                                                  -

 Loss before tax                                                           (98,985)

 Profit before tax multiplied by effective rate of corporation tax of 19%  -
 Effect of:
 Capital allowances                                                        -
 Expenses not deductible for tax purposes                                  -
 Losses carried forward                                                    (98,985)
 Tax charge in the income statement                                        -

The Company has incurred tax losses for the year and a corporation tax expense
is not anticipated. The amount of the unutilised tax losses has not been
recognised in the financial statements as the recovery of this benefit is
dependent on future profitability, the timing of which cannot be reasonably
foreseen.

On 10 June 2021, the UK Government's proposal to increase the rate of UK
corporation tax from 19% to 25% with effect from 1 April 2023 was enacted into
UK law.

 

4.   Earnings per ordinary share

The earnings and number of shares used in the calculation of loss/earnings per
ordinary share are set out below:

                                    2023
 Basic loss per share
 Loss for the financial period      (98,985)
 Weighted average number of shares  100,000,000
 Loss per share (pence)             (0.1) p

As at the end of the financial period ended 31 October 2022, there were
256,250,005 share warrants in issue, which had an anti-dilutive effect on the
weighted average number of shares.

 

5.   Other receivables
                2023

                £
 Trust account  960,130
                960,130

During the period the Company raised a total amount of £1,000,000. The funds
were deposit from investors on a trust account on behalf of the Company.

On the 1 February 2023, the net funds were transferred from the trust account
to the Company own bank account.

 

6.   Trade and other payables
                 2023

                 £
 Trade payables  1,534
 Accruals        32,500
                 34,034

 

All trade and other payables fall due for payment within one year. The
Directors consider that the carrying value of trade and other payables
approximates to their fair value.

 
7.   Share capital
 Issued and fully paid                        2023         2023

 £
                                              Number
 At 17 September 2021 - at incorporation (a)  1            1
 Total shares at £1 each                      1            1

 Share consolidation:
 1 share at £1 per share, consolidated into
 100 shares at £0.01 per share                100          1
 Total shares at £0.01 each                   100          1

 Ordinary shares issued at £0.01 (b)          4,999,900    49,999
 Ordinary shares issued at £0.01 (c)          95,000,000   950,000
 At 31 January 2023                           100,000,000  1,000,000

 

(a)  On incorporation, the Company issued 1 Ordinary Share at £1 nominal
value. On 1 November 2021, the Company consolidated the 1 Ordinary Share at
£1 in issue into 100 Ordinary Shares at £0.01 each.

(b)  On 21 March 2022, the Company issued 4,999,900 new Ordinary Shares at
£0.01 per share.

(c)   On 4 October 2022, 95,000,000 new Ordinary Shares were issued at
£0.01 per share.

 

8.   Warrants
                                             2023                                  2023

                                             Weighted average exercise price (p)   Number
 Outstanding at the beginning of the period  -                                     -
 Issued during year - investor warrants      1.5p                                  200,000,000
 Issued during year - broker warrants        1.5p                                  5,000,000
 Outstanding at the end of the period        1.5p                                  205,000,000

Investor warrants

On Admission, the Company issued 200,000,000 Investor Warrants. The Investor
Warrant entitles the holder to subscribe for one Ordinary Share at £0.015 per
Ordinary Share. The Investor Warrants are exercisable either in whole or in
part for a period of 5 years from the date of Admission. The Investor Warrants
have an accelerator clause which applies if the Company announces and signs a
sale and purchase agreement within 60 months of Admission. The Company will
serve notice on the Investor Warrant holders to exercise their warrants in
this event. When the Company serves notice, any Investor Warrants remaining
unexercised after 7 calendar days following the notification of the notice
will be cancelled.

As of 31 January 2023, none of these warrants have been converted into shares.

 

Broker warrants

On Admission, the Company issued 5,000,000 Broker Warrants to Peterhouse
Capital Limited. The Broker Warrants are exercisable at £0.015 per Ordinary
Share and are exercisable either in whole or in part for a period of 5 years
from the date of Admission. The Broker Warrants are non-transferable. The
Broker Warrants have an accelerator clause which applies if the Company
announces and signs a sale and purchase agreement within 60 months of
Admission. The Company will serve notice on the Broker Warrant holders to
exercise their warrants in this event. When the Company serves notice, any
Broker Warrants remaining unexercised after 7 calendar days following the
notification of the notice will be cancelled.

As the warrants were issued to the brokers assisting with the raise upon
re-listing, the fair value of these warrants, £25 thousands, was treated as a
share issue cost and debited against share premium.

As of 31 January 2023, none of these warrants have been converted into shares.

The following table list the inputs to the model used for the warrants plan
for the year ended 31 January 2023:

                                                       4 October 2022
 Weighted average fair values at the measurement date  £0.01
 Dividend yield                                        0%
 Expected volatility                                   70%
 Risk-free interest rate                               2.25%
 Expected life of warrant (years)                      5
 Weighted average share price                          £0.015
 Model used                                            Black-Scholes

 

 

 

9.   Financial instruments

Categories of financial assets and liabilities

The following tables set out the categories of financial instruments held by
the Company:

 Financial assets             Receivables
                    Note      2023
                               £

 Other receivables  6         960,130
                              960,130

 

 
 Financial liabilities               Financial liabilities measured at amortised cost
                           Note      2023
                                      £
 Trade and other payables  7         32,500
                                      32,500

 

The Company's financial instruments comprise of other receivables and payables
that arise directly from the Company's operations. The main purpose of these
instruments is to ensure that the Company has sufficient resources to fulfil
its investment strategy. The main risks arising from holding these financial
instruments are market risk and liquidity risk.

Market risk

All trading instruments are subject to market risk, the potential that future
changes in market conditions may make any future investments less valuable,
due to fluctuations in security prices, as well as interest and foreign
exchange rates. Market risk is directly impacted by the volatility and
liquidity in the markets in which the related underlying assets are traded.

Liquidity risks

The Company seeks to manage liquidity risk by ensuring sufficient liquid
assets are available to meet foreseeable needs and to invest liquid funds
safely and profitably. All cash balances are immediately accessible, and the
Company holds no trades payable that mature in greater than 3 months, hence a
contractual maturity analysis of financial liabilities has not been presented.
Since these financial liabilities all mature within 3 months, the Directors
believe that their carrying value reasonably equates to fair value.

Capital Disclosure

The Company defines capital as issued capital and retained earnings as
disclosed in statement of changes in equity. The Company manages its capital
to ensure that the Company will be able to continue to pursue strategic
investments and continue as a going concern. The Company does not have any
externally imposed financial requirements.

 

12. Related party transactions

During the year, the Company issued 2,700,000 ordinary shares and 5,000,000
broker warrants to Peterhouse Capital Limited, a company connected to Eran
Zucker and the Company's non-executive director.

13. Operating lease commitments

At the balance sheet date, the Company had no outstanding commitments under
operating leases.

 

14. Ultimate Controlling Party

The Company considers that there is no ultimate controlling party.

15. Post Balance Sheet Events

There were no significant Post Balance Sheet Events.

 

16. Capital Commitments

There were no contracts for capital expenditure at the period end.

17. Contingent Liabilities or assets

There were no contingent liabilities or assets at the period end.

 

 

***

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FR PPUWGPUPWGWR

Recent news on Milton Capital

See all news